Increased DJ-1 and its prognostic significance in hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 57, Issue 102-103, 2010, Pages 1247-1256

  Liu, Shunfang ^a   Yang, Zhifang ^a   Wei, Honglan ^b   Shen, Wenzhuang ^a   Liu, Jinwen ^a   Yin, Qian ^a   Li, Xingrui ^a   Yi, Jilin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

Author keywords

DJ 1; Hepatic fibrosis; Hepatocellular carcinoma; Pathogenesis; Prognosis; PTEN

Indexed keywords

DJ 1 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CHI SQUARE TEST; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER VEIN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PTEN PHOSPHOHYDROLASE; RNA, MESSENGER;

EID: 79251578640     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet 2003; 362:1907-1917.
2. Giannelli G, Antonaci S: Novel concepts in hepatocellular carcinoma: from molecular research to clinical prastice. J Clin Gastroenerol 2006; 40:842-846.
3. El-Serag HB, Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132:2557-2576.
4. Tung-Ping Poon R, Fan ST, Wong J: Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232:10-24.
5. Adachi E, Maehara S, Tsujita E, et al: Clinicopathologic risk factors for recurrence after a curative hepatic resection for hepatocellular carcinoma. Surgery 2002; 131:S148-S152.
6. Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SM, Ariga H: DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 1997;231:509-513. (Pubitemid 27214343)
7. Hod Y: Differential control of apoptosis by DJ-1 in prostate benign and cancer cells. J Cell Biochem 2004; 92:1221-1233.
8. Junn E, Taniguchi H, Jeong BS, Zhao X, Ichijo H, Mouradian MM: Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci USA 2005; 102:9691-9696.
9. MacKeigan JP, Clements CM, Lich JD, Pope RM, Hod Y, Ting JP: Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGD1alpha. Cancer Res 2003; 63:6928-6934.
10. Kim RH, Peters M, Jang Y, et al: DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005; 7:263-273.
11. Giusti L, Iacconi P, Ciregia F, et al: Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers. J Proteome Res 2008; 7:4079-4088.
12. Zhang HY, Wang HQ, Liu HM, Guan Y, Du ZX: Regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by DJ-1 in thyroid cancer cells. Endocr Relat Cancer 2008; 15:535-544. (Pubitemid 351880841)
13. Yuen HF, Chan YP, Law S, Srivastava, El-Tanani M, Mak TW, Chan KW: DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2008;17:3593-3602.
14. Davidson B, Hadar R, Schlossberg A, et al: Expression and clincal role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma. Hum Pathol 2008; 39:87-95.
15. Sitaram RT, Cairney CJ, Grabowski P, Keith WN, Hallberg B, Ljungberg B, Roos G: The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma. Int J Cancer 2009; 125:783-790.
16. Stambolic V, Suzuki A, de la Pompa JL, et al: Negative regulation of PKB/AKT-dependent cell survival by the tumor suppressor PTEN. Cell 1998; 95:29-39.
17. Sun H, Lesche R, Li DM, et al: PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA 1999; 96:6199-6204.
18. El Serag HB: Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127:S27-S34.
19. Salmena L, Carracedo A, Pandolfi PP: Tenets of PTEN tumor suppression. Cell 2008; 133:403-414.
20. Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF: The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 2008; 8:187-198.
21. Zhang D, Lim SG, Koay ES: Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma. Int J Oncol 2007; 31:577-584.
22. Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD: Characterization of RhoC expression in benign and malignant breast disease:a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol 2002; 160:579-584.
23. Clements C, McNally R, Conti B, Mak T, Ting J: DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA 2006; 103:15091-15096.
24. Fan J, Ren H, Jia N, et al: DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J Biol Chem 2008; 283:4022-4030.
25. Mo JS, Kim MY, Ann EJ, Hong JA, Park HS: DJ-1 modulates UV-induced oxidative stress signaling through the suppression of MEKK1 and cell death. Cell Death Differ 2008; 15:1030-1041.
26. Soresi M, Magliarisi C, Campagna P, et al: Usefulness of a-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res 2003; 23:1747-1753.
27. Shimada K, Sano T, Sakamoto Y, Kosuge T: A long term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy. Cancer 2005; 104:1939-1947.
28. Schmitz KJ, Wohlschlaeger J, Lang H, et al: Activation of the ERK and AKT signaling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol 2008; 48:83-90.
29. White ES, Thannickal VJ, Carskadon SL, et al: Integrin alpha4betal regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10. Am J Respir Crit Care Med 2003; 168:436-442.
30. White ES, Atrasz RG, Hu B, et al: Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). Am J Respir Crit Care Med 2006; 173:112-121.
31. Reif S, Lang A, Lindquist JN, et al: The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type collagen expression. J Biol Chem 2003; 278:8083-8090.
32. Parsons CJ, Takashima M, Rippe RA: Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol 2007; 22:S79-84.
33. Takashima M, Parsons CJ, Ikejima K, Watanabe S, White ES, Rippe RA: The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation. J Gastroenterol 2009; 44:847-855.